CA2511970C — Urea derivatives useful in the treatment of heart failure
Assigned to Cytokinetics Inc · Expires 2012-06-26 · 14y expired
What this patent protects
Certain substituted urea derivatives, represented by Formula I: (see formula I) wherein: R1 is represented by Formula II: (see formula II) selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic he…
USPTO Abstract
Certain substituted urea derivatives, represented by Formula I: (see formula I) wherein: R1 is represented by Formula II: (see formula II) selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.